PEGylation of αα-Hb using succinimidyl propionic acid PEG 5K: Conjugation chemistry and PEG shell structure dictate respectively the oxygen affinity and resuscitation fluid like properties of PEG αα-Hbs
Source abstract
Abstract
PEGylation of intramolecularly crosslinked Hb has been studied here to overcome the limitation of dissociation of Hb tetramers. New hexa and deca PEGylated low oxygen affinity PEG-ααHbs have been generated. Influence of PEG conjugation chemistry and the PEG shell structure on the functional properties as well as PEGylation induced plasma expander like properties of the protein has been delineated. The results have established that in the design of PEG-Hbs as oxygen therapeutics, the influence of conjugation chemistry and the PEG shell structure on the oxygen affinity of Hb needs to be optimized independently besides optimizing the PEG shell structure for inducing resuscitation fluid like properties.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Hemoglobin structure and function · Heme Oxygenase-1 and Carbon Monoxide · Mass Spectrometry Techniques and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Hematology Division, ,
,
References (42)
Show source-provided references
1. 10.1081/BIO-20006636510.1081/BIO-200066365 ↗
2. 10.1042/BJ2007023810.1042/BJ20070238 ↗
3. 10.1111/j.1778-428X.2007.00091.x10.1111/j.1778-428X.2007.00091.x ↗
4. 10.1016/0003-2697(69)90118-310.1016/0003-2697(69)90118-3 ↗
5. 10.3109/10731199.2011.57956810.3109/10731199.2011.579568 ↗
6. 10.3109/21691401.2012.76237010.3109/21691401.2012.762370 ↗
7. 10.1016/0301-4622(90)88031-M10.1016/0301-4622(90)88031-M ↗
8. 10.1016/j.resuscitation.2008.04.02010.1016/j.resuscitation.2008.04.020 ↗
9. 10.1016/S0021-9258(18)67605-710.1016/S0021-9258(18)67605-7 ↗
10. 10.1007/978-1-4419-7756-4_1210.1007/978-1-4419-7756-4_12 ↗
11. 10.1016/j.mvr.2008.07.00210.1016/j.mvr.2008.07.002 ↗
12. 10.1016/S0021-9258(18)90589-210.1016/S0021-9258(18)90589-2 ↗
13. 10.1042/BJ2005066310.1042/BJ20050663 ↗
14. 10.1042/BJ2006143410.1042/BJ20061434 ↗
15. 10.1021/bi800906z10.1021/bi800906z ↗
16. 10.1021/bi801880y10.1021/bi801880y ↗
17. 10.1146/annurev.bioeng.8.061505.09571310.1146/annurev.bioeng.8.061505.095713 ↗
18. 10.1021/bi010051o10.1021/bi010051o ↗
19. 10.1007/s10930-006-9010-y10.1007/s10930-006-9010-y ↗
20. 10.1016/j.bbapap.2008.03.01410.1016/j.bbapap.2008.03.014 ↗
21. 10.1021/bc900170e10.1021/bc900170e ↗
22. Manjula BN, Acharya AS. 2003. Purification and molecular analysis of hemoglobin by high-performance liquid chromatography. Methods Mol Med: Hemoglobin Disord. 82:31–47.
23. 10.1021/bc020073310.1021/bc0200733 ↗
24. 10.1007/s10930-005-7837-210.1007/s10930-005-7837-2 ↗
25. 10.1007/s10930-009-9185-010.1007/s10930-009-9185-0 ↗
26. 10.1021/bi062146210.1021/bi0621462 ↗
27. 10.3109/1073119920911967710.3109/10731199209119677 ↗
28. 10.3109/1073119990911769310.3109/10731199909117693 ↗
29. 10.1046/j.1537-2995.1995.35795357876.x10.1046/j.1537-2995.1995.35795357876.x ↗
30. 10.1152/ajpheart.01090.201110.1152/ajpheart.01090.2011 ↗
31. 10.1152/ajpheart.00307.200310.1152/ajpheart.00307.2003 ↗
32. 10.1089/ars.2007.163310.1089/ars.2007.1633 ↗
33. 10.1089/ars.2009.251910.1089/ars.2009.2519 ↗
34. 10.1111/j.1525-1594.2008.00697.x10.1111/j.1525-1594.2008.00697.x ↗
35. 10.1016/S0301-4622(97)00079-310.1016/S0301-4622(97)00079-3 ↗
36. 10.1046/j.1537-2995.2003.00341.x10.1046/j.1537-2995.2003.00341.x ↗
37. 10.1042/BJ2006080910.1042/BJ20060809 ↗
38. 10.1021/bc800266610.1021/bc8002666 ↗
39. 10.1159/00003120010.1159/000031200 ↗
40. 10.1081/BIO-20004663410.1081/BIO-200046634 ↗
41. 10.1016/j.bbapap.2008.04.03210.1016/j.bbapap.2008.04.032 ↗
42. 10.1097/01.CCM.0000172648.55309.1310.1097/01.CCM.0000172648.55309.13 ↗